PML and acute promyelocytic leukemia: By characterizing for the first time the APL metabolic background, we demonstrate that PML::RARα inhibits glycolysis via AKT degradation, promotes TCA, and favors LCFA catabolism, exposing APL cells to strong dependency and vulnerabilities to OXPHOS inhibition.